Colby Souders

Colby Souders is a seasoned biotechnology professional currently serving as the Chief Scientific Officer for Biopharma at Twist Bioscience since July 2024, with additional responsibilities as an Advisor and Chief Scientific Officer at BrickBio, Inc. since January 2023. Previous roles include Senior Director of R&D at Twist Bioscience (December 2021 - January 2023), Chief Scientific Officer and Chief Technology Officer at Abveris (August 2018 - January 2023), and Antibody and Protein Engineering at Kanyos Bio (February 2016 - August 2018), where Colby focused on developing novel Fab-Fusion proteins for therapeutic applications. Earlier career experiences encompass R&D Scientist and Assistant Professor of Medicine at MassBiologics (July 2012 - February 2016) and extensive research during graduate studies at the University of South Carolina and Texas A&M University School of Medicine, culminating in multiple doctoral degrees in Biomedical Sciences and Cell and Molecular Biology. Academic background includes a Bachelor of Arts in Biochemistry and Neuroscience from Colby College.